Rock Springs Capital Management LP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$23,286,952
-24.4%
1,211,600
+0.0%
0.62%
-14.9%
Q2 2023$30,793,788
-21.0%
1,211,400
+12.4%
0.73%
-21.2%
Q1 2023$38,966,085
-8.7%
1,077,9000.0%0.93%
-9.4%
Q4 2022$42,684,840
+16.4%
1,077,900
+37.0%
1.03%
+8.4%
Q3 2022$36,674,000
+8.2%
787,000
+1.8%
0.95%
-4.0%
Q2 2022$33,894,000
-35.1%
773,300
+7.2%
0.99%
-25.0%
Q1 2022$52,186,000
-9.8%
721,500
+1.1%
1.31%
-1.7%
Q4 2021$57,884,000
-21.8%
714,000
+12.3%
1.34%
-14.1%
Q3 2021$73,983,000
-16.0%
635,700
+19.7%
1.56%
-10.6%
Q2 2021$88,034,000
+30.1%
531,000
+9.5%
1.74%
+17.9%
Q1 2021$67,658,000
-1.0%
485,000
+22.8%
1.48%
+1.8%
Q4 2020$68,375,000
+27.2%
395,000
+2.3%
1.45%
+6.3%
Q3 2020$53,770,000
+16.6%
386,0000.0%1.36%
+7.8%
Q2 2020$46,115,000
+33.3%
386,000
+11.6%
1.26%
-11.5%
Q1 2020$34,593,000
+5.5%
346,000
+24.0%
1.43%
+38.0%
Q4 2019$32,794,000
+57.3%
279,000
+15.1%
1.04%
+24.7%
Q3 2019$20,848,000
+64.5%
242,500
+24.0%
0.83%
+81.0%
Q2 2019$12,674,000
+484.3%
195,500
+463.4%
0.46%
+446.4%
Q1 2019$2,169,00034,7000.08%
Other shareholders
NEVRO CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders